ReviewOncology letters2026
Regulatory roles of N6-methyladenosine methylation factors in melanoma invasion and metastasis (Review).
Review in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melanoma, a malignant skin tumor, has an increasing incidence rate annually and affects the skin, eyes and mucous membranes. Despite advancements in early diagnosis and treatment improving survival rates, invasion and metastasis of melanoma remain major challenges. In-depth research into the pathogenesis of melanoma and novel therapies is essential to enhance patient outcomes. N6-methyladenosine (m6A) methylation, a key RNA modification, regulates gene expression and cellular functions, influencing cell proliferation, differentiation, apoptosis and signal transduction. It is implicated in various diseases, including tumors. In melanoma, m6A methylation regulates genes involved in tumor invasion and metastasis, impacting cell migration and drug resistance. Understanding the role of m6A methylation in melanoma can uncover disease mechanisms and inform therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.